Alphatec ( (ATEC) ) has released its Q1 earnings. Here is a breakdown of the information Alphatec presented to its investors.
Alphatec Holdings, Inc. is a medical device company specializing in innovative solutions for spine surgery, aiming to revolutionize surgical approaches through clinical distinction. In its first quarter of 2025, Alphatec reported a significant increase in revenue, with surgical revenue growing by 24% and total revenue by 22%. The company also successfully refinanced its convertible debt to a 2030 maturity, reflecting strong financial management. Key financial metrics for the quarter included a total revenue of $169 million, a GAAP gross margin of 69%, and an adjusted EBITDA of $11 million, indicating a 6% margin. The company also noted a notable improvement in free cash use by $55 million compared to the previous year. Looking ahead, Alphatec has raised its full-year revenue guidance to $734 million, expecting a 20% growth, and anticipates an adjusted EBITDA of approximately $78 million, showcasing confidence in its strategic direction and continued growth potential.